Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders
- PMID: 16455889
- PMCID: PMC1392647
- DOI: 10.1128/JCM.44.2.389-394.2006
Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders
Abstract
Several reports have described a high rate of false-positive Aspergillus galactomannan (GM) test results for patients treated with piperacillin-tazobactam. In this retrospective study, we first examined the relationships between intravenous administration of three beta-lactam antibiotics and the occurrence of false-positive GM test results in hematology patients. We then estimated the kinetics of clearance of GM after the cessation of treatment. Sequential serum samples from 69 patients that had received beta-lactams were analyzed by using a Platelia Aspergillus test. A significant association was found between GM positivity (>/=0.5) and the administration of beta-lactams (P < 0.0001). The direct role of beta-lactams in patients' serum positivity was assessed by testing 39 batches of beta-lactams, of which 27 were positive for GM. None of the latter were positive according to a fungus- and Aspergillus-specific PCR. The kinetics of the decrease of GM was analyzed on sequential serum samples obtained after treatment. By use of a nonlinear regression model, the average time to negative antigen was assessed to be 5.5 days (95% confidence interval [CI], 4.1 to [7.0]), with a half-life of elimination of GM of 2.4 days (95% CI, 1.8 to 3.0). This study confirms that the administration of beta-lactams containing GM is responsible for false-positive diagnostic results, even up to 5 days after the cessation of treatment.
Figures


Similar articles
-
Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments.J Clin Microbiol. 2005 Oct;43(10):5214-20. doi: 10.1128/JCM.43.10.5214-5220.2005. J Clin Microbiol. 2005. PMID: 16207986 Free PMC article.
-
The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.Infection. 2010 Jun;38(3):217-21. doi: 10.1007/s15010-010-0003-6. Epub 2010 Mar 17. Infection. 2010. PMID: 20237947
-
False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.Transplantation. 2009 Jan 27;87(2):256-60. doi: 10.1097/TP.0b013e31819288d5. Transplantation. 2009. PMID: 19155981
-
[The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].Zhonghua Nei Ke Za Zhi. 2006 Dec;45(12):992-5. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17326997 Chinese.
-
[Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].Rev Iberoam Micol. 2003 Sep;20(3):103-10. Rev Iberoam Micol. 2003. PMID: 15456366 Review. Spanish.
Cited by
-
Galactomannan testing for early diagnosis of Exserohilum rostratum infection.J Clin Microbiol. 2013 Aug;51(8):2800-1. doi: 10.1128/JCM.00955-13. Epub 2013 May 29. J Clin Microbiol. 2013. PMID: 23720789 Free PMC article. No abstract available.
-
Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children.J Clin Microbiol. 2021 Aug 18;59(9):e0327620. doi: 10.1128/JCM.03276-20. Epub 2021 Aug 18. J Clin Microbiol. 2021. PMID: 33883182 Free PMC article.
-
The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.J Clin Microbiol. 2010 Nov;48(11):4083-8. doi: 10.1128/JCM.01183-10. Epub 2010 Aug 18. J Clin Microbiol. 2010. PMID: 20720025 Free PMC article.
-
Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1437-41. doi: 10.1007/s10096-015-2370-5. Epub 2015 Apr 17. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25894983
-
Opportunistic invasive fungal infections: diagnosis & clinical management.Indian J Med Res. 2014 Feb;139(2):195-204. Indian J Med Res. 2014. PMID: 24718393 Free PMC article. Review.
References
-
- Adam, O., A. Auperin, F. Wilquin, J. H. Bourhis, B. Gachot, and E. Chachaty. 2004. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin. Infect. Dis. 38:917-920. - PubMed
-
- Ansorg, R., R. van den Boom, and P. M. Rath. 1997. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 40:353-357. - PubMed
-
- Ascioglu, S., J. H. Rex, B. de Paw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A Stevens, and T. J. Walsh. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14. - PubMed
-
- Bretagne, S., A. Marmorat-Khuong, M. Kuentz, J. P. Latgé, and F. Derouin. 1997. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J. Infect. 35:7-15. - PubMed
-
- Davidian, M., and D. M. Giltinan. 1995. Nonlinear models for repeated measurement data. Chapman and Hall/CRC, Boca Raton, Fla.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical